Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma
出版年份 2019 全文链接
标题
Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high-MYC medulloblastoma
作者
关键词
-
出版物
NEUROPATHOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-01-11
DOI
10.1111/neup.12534
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity
- (2017) Laurel T. Bate-Eya et al. EUROPEAN JOURNAL OF CANCER
- EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
- (2017) Faizaan Mohammad et al. NATURE MEDICINE
- Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
- (2016) Vijay Ramaswamy et al. ACTA NEUROPATHOLOGICA
- Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres
- (2016) Manabu Natsumeda et al. BRAIN PATHOLOGY
- DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets
- (2016) A. R. Hanaford et al. CLINICAL CANCER RESEARCH
- Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic
- (2016) F Volpin et al. ONCOGENE
- Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
- (2015) Rebecca M. Hill et al. CANCER CELL
- ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors
- (2015) Ping Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting histone methyltransferase EZH2 as cancer treatment
- (2014) Y. Kondo JOURNAL OF BIOCHEMISTRY
- Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma
- (2014) Sama Ahsan et al. Acta Neuropathologica Communications
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
- (2013) K.-M. Chan et al. GENES & DEVELOPMENT
- cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome
- (2013) Yazmin Odia et al. JOURNAL OF NEURO-ONCOLOGY
- Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma
- (2012) Adrian M. Dubuc et al. ACTA NEUROPATHOLOGICA
- Targeting the enhancer of zeste homologue 2 in medulloblastoma
- (2012) Irina Alimova et al. INTERNATIONAL JOURNAL OF CANCER
- Novel mutations target distinct subgroups of medulloblastoma
- (2012) Giles Robinson et al. NATURE
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells
- (2012) Irina Alimova et al. NEURO-ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells
- (2010) F. Orzan et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells
- (2009) André O von Bueren et al. BMC CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started